House of Representative has order for a fresh probe into collapse of automobile company in the Country.
9Janewshub.com.ng reports that the the House of Representatives on Thursday ordered an investigation into the collapse of automobile assembly plants in the country with the view to making insightful recommendations for the immediate resuscitation of the plants.
The House also mandated its Committee on Industry to carry out the probe, it equally mandated it committee on Legislative Compliance to ensure adherence.
These resolutions followed the adoption of a motion on the ‘Need to Revive the Moribund Automobile Assembly Plants in Nigeria by Hon. Abdullahi Ibrahim Ali Halims.’
The House noted the socio-economic benefits of automobile industries in a developing country like Nigeria is enormous and cannot be ever-emphasized as it will drastically reduce unemployment, thus reducing insecurity resulting from joblessness.
It also recalled that in the 1970s up till the early 1990s, automobile companies like Volkswagen, Peugeot, Leyland, ANAMCO, etc. had functional assembly plants located in different cities across the country and contributed positively to the economy.
The House said it was “cognizant that the current economic challenges facing Nigeria necessitate the need to device workable means of addressing the ugly trend, hence the need to revive the moribund auto-mobile assembly plants by negotiating with investors interested in investing in Nigeria auto-mobile plants, as this will save billions of forex used in the importation of vehicles.”
Similarly, the House also on Thursday mandated the Committee on Healthcare Services to investigate the issuance of fake COVID-19 vaccination cards in the country.
The Committee is also to investigate the activities of the COVID-19 vaccination units, especially as it relates to their records of vaccinations to ensure that such records are duly kept in the approved database.
It is also to probe the funds spent on maintaining a National Database of COVID-19 vaccination and the inability of key government agencies to have real-time access to the COVID-19 vaccination database.